Dr Preston confirmed his views to the Inquiry that "The Department of Health should have responded by pushing for ways to inactivate the virus in the blood, or given patients the choice of an alternative." Read more about Dr Preston confirmed his views to the Inquiry that "The Department of Health should have responded by pushing for ways to inactivate the virus in the blood, or given patients the choice of an alternative."
Dr Preston told the Observer "in 1978 we showed quite definitely that non-A, non-B was a very serious disorder. The Department of Health should have responded by pushing for ways to inactivate the virus in the blood, or given patients the choice of an alternative." Read more about Dr Preston told the Observer "in 1978 we showed quite definitely that non-A, non-B was a very serious disorder. The Department of Health should have responded by pushing for ways to inactivate the virus in the blood, or given patients the choice of an alternative."
At the Sheffield haemophilia centre, the amount of Factor 8 and Factor 9 given to patients was very much less than other reference centres, although Dr Preston did not think this reflected a deliberate decision to take a conservative approach. Read more about At the Sheffield haemophilia centre, the amount of Factor 8 and Factor 9 given to patients was very much less than other reference centres, although Dr Preston did not think this reflected a deliberate decision to take a conservative approach.
The Sheffield haemophilia centre was a reference centre, but not one of the larger centres. At Sheffield, there was a particular focus on hepatitis and liver disease, with significant research being undertaken there. Read more about The Sheffield haemophilia centre was a reference centre, but not one of the larger centres. At Sheffield, there was a particular focus on hepatitis and liver disease, with significant research being undertaken there.
Sheffield Haemophilia Centre participated in a formal trial of an Armour heat-treated concentrate beginning in April 1984. Two patients became ill with hepatitis. Dr Preston's recollection was that they withdrew from that study and moved to a study with colleagues in other centres, using an Alpha product. Read more about Sheffield Haemophilia Centre participated in a formal trial of an Armour heat-treated concentrate beginning in April 1984. Two patients became ill with hepatitis. Dr Preston's recollection was that they withdrew from that study and moved to a study with colleagues in other centres, using an Alpha product.
In his statement to the Lindsay Tribunal, Dr Preston asserted that the amount of Factor VIII and Factor IX given in the Haemophilia Centre was much less than that in other centres. Read more about In his statement to the Lindsay Tribunal, Dr Preston asserted that the amount of Factor VIII and Factor IX given in the Haemophilia Centre was much less than that in other centres.
In his statement to the Lindsay Tribunal, Dr Preston believed that in 1978 it had been shown that Non A-Non B Hepatitis was a very serious disorder. Read more about In his statement to the Lindsay Tribunal, Dr Preston believed that in 1978 it had been shown that Non A-Non B Hepatitis was a very serious disorder.
The first director of the Haemophilia Centre at Sheffield was Professor Eddie Blackburn. Read more about The first director of the Haemophilia Centre at Sheffield was Professor Eddie Blackburn.
Eric Preston in his statement to the Lindsay Tribunal noted that the haemophilia centre at Sheffield was first based at the Royal Infirmary before moving to Royal Hallamshire Hospital. It was a reference centre but not one of the larger reference centres. Read more about Eric Preston in his statement to the Lindsay Tribunal noted that the haemophilia centre at Sheffield was first based at the Royal Infirmary before moving to Royal Hallamshire Hospital. It was a reference centre but not one of the larger reference centres.
In a HIV Haemophilia litigation report, Dr Mayne suggested that the risk of NANB could progress to Hepatitis was known in 1977 but the full significance of its effects was not investigated until the mid-late 1980's. Read more about In a HIV Haemophilia litigation report, Dr Mayne suggested that the risk of NANB could progress to Hepatitis was known in 1977 but the full significance of its effects was not investigated until the mid-late 1980's.